Trials / Completed
CompletedNCT00360464
A Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases
A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases In Japan Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 16 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the clinical efficacy and safety in patients with Acute Bronchitis or Secondary Infection of Chronic Respiratory Diseases receiving a dose of 2 g of azithromycin in the SR formulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin SR |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2007-06-01
- Completion
- 2007-06-01
- First posted
- 2006-08-04
- Last updated
- 2011-04-21
Locations
19 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00360464. Inclusion in this directory is not an endorsement.